DistantNews
Support us
๐Ÿ‡จ๐Ÿ‡ฉ DR Congo /Health & Science

WHO Delivers 70,000 Ervebo Vaccine Doses to DRC to Combat Ebola Outbreak

From Radio Okapi · () French

Translated from French, summarized and contextualized by DistantNews.

At a glance

News Official statement Ongoing story
  • The World Health Organization (WHO) announced the arrival of 70,000 doses of the Ervebo vaccine in the Democratic Republic of Congo (DRC).
  • These vaccines aim to bolster the response to the ongoing Ebola epidemic in the eastern and northeastern regions.
  • The doses will be used to protect frontline health workers and conduct clinical trials for the Bundibugyo strain.

The World Health Organization (WHO) has announced the delivery of 70,000 doses of the Ervebo vaccine to the Democratic Republic of Congo (DRC). This significant shipment arrives as the DRC grapples with the escalating Ebola virus epidemic in its eastern and northeastern provinces.

The newly arrived vaccines are earmarked for critical use. A substantial portion will be allocated to protect healthcare professionals who are on the front lines of combating the outbreak. Additionally, 20,000 doses are designated for a clinical trial aimed at assessing the vaccine's effectiveness against the Bundibugyo strain, which is currently driving the epidemic.

This initiative by the WHO underscores the international effort to contain the Ebola outbreak in the DRC. By providing essential vaccines and supporting research, the organization seeks to strengthen the country's response capabilities and mitigate the spread of the deadly virus.

DistantNews Editorial

Originally published by Radio Okapi in French. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.